Article 1: A 12-Year Clinical Evaluation of a Three-Step Dentin Adhesive in Noncarious Cervical Lesions 

1. What percentage of all restorations were retained among patients available for the 12-year follow-up examination?
Select answer A. 56 percent B. 71 percent C. 89 percent D. 98 percent

2. What percentage of all restorations were rated Alfa for marginal adaptation (marginal integrity) at the 12-year follow-up examination?
Select answer A. 79 percent B. 82 percent C. 88 percent D. 90 percent

3. Although the differences were not statistically significant, for which one of the following criteria did group A have a higher percentage of restorations rated as Alfa?
Select answer A. retention B. marginal discoloration C. recurrent caries D. marginal integrity

4. Each of the following was true for retention failures in group B, compared with group A, except which one?
Select answer A. Patients were more likely to be male. B. Teeth were more likely to be posterior. C. Teeth were more likely to have been in stressful occlusion. D. Internal angles were larger.

Article 2: The Potentially Harmful Medical Consequences of Untreated Sleep-Disordered Breathing: The Evidence Supporting Brain Damage 

1. In a cross-sectional study of 31 children, which one of the following was not reduced for the children with obstructive sleep apnea?
Select answer A. intelligence quotient B. verbal working memory C. verbal fluency D. motor speed

2. What was the adjusted hazard ratio for stroke after 10 years among adult patients with apnea hypopnea index scores of 5 or higher?
Select answer A. 2.89 B. 3.42 C. 3.99 D. 4.56

3. What odds ratio for development of carotid plaques was observed among heavy snorers compared with mild snorers?
Select answer A. 2.7 B. 4.9 C. 7.6 D. 10.5

4. After four months of treatment with continuous positive airway pressure, which one of the following performance measures did not return to normal levels?
Select answer A. executive functions B. attention C. visuospatial learning D. motor performance

Article 3: Flumazenil Reversal of Sublingual Triazolam: A Randomized Controlled Clinical Trial 

1. In a mail survey of members of the Dental Organization for Conscious Sedation, what percentage of cases involved an adverse event?
Select answer A. 3.5 percent B. 8.7 percent C. 16.3 percent D. 21.8 percent

2. By what percentage did bispectral index scores increase at the 150-minute observation point, relative to 120-minute baseline scores, for patients receiving flumazenil?
Select answer A. 14 percent B. 23 percent C. 29 percent D. 32 percent

3. How long did the increase in bispectral index scores persist after administration of flumazenil?
Select answer A. throughout the remaining 240 minutes of observation B. for three 30-minute observation periods C. for two 30-minute observation periods D. for one 30-minute observation period

4. How long did the increase in Observer’s Assessment of Alertness/Sedation scores persist after administration of flumazenil?
Select answer A. throughout the remaining 240 minutes of observation B. for three 30-minute observation periods C. for two 30-minute observation periods D. for one 30-minute observation period

Article 4: An Updated Concept of Coagulation With Clinical Implications 

1. Which one of the following coagulation factors is associated only with the extrinsic pathway of the coagulation cascade/waterfall model?
Select answer A. factor VII B. factor VIII C. factor V D. factor XII

2. In the initiation phase of the proposed cell-based model of coagulation, which coagulation factor is initially activated by tissue factor–bearing cells released through a break in the vascular wall?
Select answer A. factor VII B. factor VIII C. factor V D. factor XII

3. What is the key factor in the amplification phase of the cell-based model of coagulation?
Select answer A. tenase B. prothrombinase C. thrombin D. fibrin

4. Which one of the following, when deficient, will yield a prolonged activated partial thromboplastin time test result and indicate a significant potential for impaired hemostasis?
Select answer A. factor XII B. factor IX C. high-molecular-weight kininogen D. prekallikrein

To submit your test answers, click the "Submit" button below. The JADA CE payment screen on the University of Colorado Health Sciences Center Web site will open in a new window. Following payment, confirmation of the credits you've earned will be displayed for printing. An additional confirmation will be sent by e-mail and postal mail.

Please note, you will not have the opportunity to revise your answers once you've submitted the test.